- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.42 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x 3IG: N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE(Non-covalent)
3IG.2: 20 residues within 4Å:- Chain A: T.11, Q.12, Y.13, V.29, D.31, G.33, Y.76, S.77, T.78, P.111, F.112, L.114, A.115, F.117, V.120, Y.155, D.219, T.220, G.221, S.223
18 PLIP interactions:18 interactions with chain A- Hydrophobic interactions: A:V.29, A:Y.76, A:Y.76, A:Y.76, A:P.111, A:F.112, A:A.115, A:V.120
- Hydrogen bonds: A:Y.13, A:G.33, A:S.77, A:T.78, A:G.221
- Water bridges: A:Q.12, A:S.77, A:S.77
- Salt bridges: A:D.31, A:D.219
3IG.4: 19 residues within 4Å:- Chain B: T.11, Q.12, Y.13, V.29, D.31, G.33, Y.76, S.77, T.78, P.111, L.114, A.115, F.117, V.120, Y.155, D.219, T.220, G.221, S.223
16 PLIP interactions:16 interactions with chain B- Hydrophobic interactions: B:Y.76, B:P.111, B:A.115, B:F.117, B:V.120, B:V.120
- Hydrogen bonds: B:Y.13, B:S.77, B:T.78, B:T.78, B:G.221
- Water bridges: B:Q.12, B:T.78, B:T.78
- Salt bridges: B:D.31, B:D.219
3IG.6: 20 residues within 4Å:- Chain C: T.11, Q.12, Y.13, V.29, D.31, G.33, Y.76, S.77, T.78, P.111, F.112, L.114, A.115, F.117, V.120, Y.155, D.219, T.220, G.221, S.223
18 PLIP interactions:18 interactions with chain C- Hydrophobic interactions: C:V.29, C:Y.76, C:Y.76, C:Y.76, C:P.111, C:F.112, C:A.115, C:V.120
- Hydrogen bonds: C:Y.13, C:G.33, C:S.77, C:T.78, C:G.221
- Water bridges: C:Q.12, C:S.77, C:S.77
- Salt bridges: C:D.31, C:D.219
3IG.8: 19 residues within 4Å:- Chain D: T.11, Q.12, Y.13, V.29, D.31, G.33, Y.76, S.77, T.78, P.111, L.114, A.115, F.117, V.120, Y.155, D.219, T.220, G.221, S.223
16 PLIP interactions:16 interactions with chain D- Hydrophobic interactions: D:Y.76, D:P.111, D:A.115, D:F.117, D:V.120, D:V.120
- Hydrogen bonds: D:Y.13, D:S.77, D:S.77, D:T.78, D:G.221
- Water bridges: D:Q.12, D:T.78, D:T.78
- Salt bridges: D:D.31, D:D.219
3IG.10: 20 residues within 4Å:- Chain E: T.11, Q.12, Y.13, V.29, D.31, G.33, Y.76, S.77, T.78, P.111, F.112, L.114, A.115, F.117, V.120, Y.155, D.219, T.220, G.221, S.223
18 PLIP interactions:18 interactions with chain E- Hydrophobic interactions: E:V.29, E:Y.76, E:Y.76, E:Y.76, E:P.111, E:F.112, E:A.115, E:V.120
- Hydrogen bonds: E:Y.13, E:G.33, E:T.78, E:T.78, E:G.221
- Water bridges: E:Q.12, E:S.77, E:S.77
- Salt bridges: E:D.31, E:D.219
3IG.12: 19 residues within 4Å:- Chain F: T.11, Q.12, Y.13, V.29, D.31, G.33, Y.76, S.77, T.78, P.111, L.114, A.115, F.117, V.120, Y.155, D.219, T.220, G.221, S.223
15 PLIP interactions:15 interactions with chain F- Hydrophobic interactions: F:Y.76, F:P.111, F:A.115, F:F.117, F:V.120, F:V.120
- Hydrogen bonds: F:Y.13, F:G.33, F:S.77, F:S.77, F:T.78, F:G.221
- Water bridges: F:Q.12
- Salt bridges: F:D.31, F:D.219
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Holsworth, D.D. et al., Ketopiperazine-Based Renin Inhibitors: Optimization of the "C" Ring. BIOORG.MED.CHEM.LETT. (2006)
- Release Date
- 2006-06-13
- Peptides
- Renin: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.42 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x 3IG: N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Holsworth, D.D. et al., Ketopiperazine-Based Renin Inhibitors: Optimization of the "C" Ring. BIOORG.MED.CHEM.LETT. (2006)
- Release Date
- 2006-06-13
- Peptides
- Renin: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
B